Picture of Cytosorbents logo

CTSO Cytosorbents Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Cytosorbents, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19.3-7.84-24.6-32.8-28.5
Depreciation
Non-Cash Items3.382.329.187.263.03
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.45-0.7580.642-3.562.36
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Cash from Operating Activities-16.8-5.61-14-28.2-21.7
Capital Expenditures-1.52-1.68-4.28-6.46-0.936
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-1.52-1.68-4.28-6.46-0.936
Financing Cash Flow Items-0.004-0.37500
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities8.1866.30.7154.9614.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10.159.2-17.6-30-8.22